ReviewJournal of the Endocrine Society2017
Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers.
Review in Journal of the Endocrine Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.Journal of the National Comprehensive Cancer Network : JNCCN · 2020Guideline
- Tumor risks and surveillance outcomes inEndocrine oncology (Bristol, England) · 2026Article
- Optimal Screening for Hereditary Head and Neck Paraganglioma in Asymptomatic SDHx Variant Carriers in the Netherlands.Journal of neurological surgery. Part B, Skull base · 2025Article
- Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.Nature reviews. Endocrinology · 2024Review
- Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.The lancet. Diabetes & endocrinology · 2023Review
- A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant.Familial cancer · 2023Article
- Radiologic screening and surveillance in hereditary cancers.European journal of radiology open · 2022Article
- Large Retroperitoneal Paraganglioma Associated with Germline Mutation of the Succinate Dehydrogenase Gene.Journal of kidney cancer and VHL · 2021Article
- Co-existent Epicardial Paraganglioma and Anterior Mediastinal Thymoma.Journal of radiology case reports · 2020Article
- Pediatric applications of Dotatate: early diagnostic and therapeutic experience.Pediatric radiology · 2020Review
- Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.Pediatric nephrology (Berlin, Germany) · 2020Review
- Tinnitus With Unexpected Spanish Roots: Head and Neck Paragangliomas Caused by SDHAF2 Mutation.Journal of the Endocrine Society · 2020Article
- Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.Cancer metastasis reviews · 2019Review
- Brown adipose activation and reversible beige coloration in adipose tissue with multiple accumulations ofClinical case reports · 2019Article
- An analysis of surveillance screening for SDHB-related disease in childhood and adolescence.Endocrine connections · 2019Article
- The genetic basis of isolated mitochondrial complex II deficiency.Molecular genetics and metabolismReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been a significant increase in the availability of testing for pheochromocytoma and paraganglioma (PPGL) germline susceptibility genes. As more patients with genetic mutations are identified, cascade genetic testing of family members is also increasing. This results in identifying genetic predispositions at a much earlier age. With our current understanding of familial PPGL syndromes, lifelong surveillance is required. This review focuses on carriers of succinate dehydrogenase (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.